MacroGenics
MGNX
$4.36
Share price
-14.75%
Change (1 day)
-28.44%
Change (1 year)
Categories
MacroGenics (MGNX) Fails to deliver data
Key failure to deliver metrics for MacroGenics:
- Last SEC data release: 2024-04-30
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: $4.27 M
- Last year FTD volume: $4.83 M
Failures to deliver for MacroGenics (MGNX) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for MacroGenics (MGNX) - since 2013
Volume in USD (price x number of shares), data since 2013MacroGenics (MGNX) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $4.28 M | 227.98% |
| 2023 | $1.3 M | -18.82% |
| 2022 | $1.6 M | -70.7% |
| 2021 | $5.49 M | -86.47% |
| 2020 | $40.6 M | 56.41% |
| 2019 | $25.96 M | 1465.1% |
| 2018 | $1.65 M | -73.54% |
| 2017 | $6.26 M | 85.1% |
| 2016 | $3.38 M | -55.49% |
| 2015 | $7.6 M | -35.48% |
| 2014 | $11.79 M | 65.01% |
| 2013 | $7.14 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Pfizer PFE | $10.32 M | $0.31 B | 🇺🇸 USA |
 Eli Lilly LLY | $56.64 M | $0.12 B | 🇺🇸 USA |
 Amgen AMGN | $52.25 M | $0.21 B | 🇺🇸 USA |
 Gilead Sciences GILD | $3.99 M | $0.25 B | 🇺🇸 USA |
 Merck MRK | $6.57 M | $0.15 B | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $0.23 B | $0.32 B | 🇺🇸 USA |
 Xencor XNCR | $0.15 M | $1.86 M | 🇺🇸 USA |